MedTrace Logo

Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage

NCT01311024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2341

Last updated 2021-03-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the indirect effects of a pneumococcal conjugate vaccine administered to infants on vaccinees' elder non-vaccinated siblings aged 3 to 7 years.

Conditions

  • Pneumococcal Infections

Interventions

BIOLOGICAL

PCV GSK1024850A

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)

BIOLOGICAL

hepatitis B vaccine or hepatitis A vaccine

2 to 4 doses administered to the siblings in the cluster-randomized Finnish Invasive pneumococcal Disease Trial (ClinicalTrials.gov Identifier:NCT00861380)

Sponsors & Collaborators

Principal Investigators

  • Arto A Palmu, M.D. · Finnish Institute for Health and Welfare

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-06-30
Completion
2017-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01311024 on ClinicalTrials.gov